A breakthrough radiotherapy being rolled out on the NHS could wipe out prostate cancer in most men in just a single session, a trial found.
From earlier this month, some radiotherapy centres in England started to let men swap from standard radiotherapy that needs 20 sessions to a new high-power version that can be done in five.
Now an early stage trial by the Oncology Institute of Southern Switzerland suggests this could be safely and effectively reduced further to just one.
The precision treatment, named stereotactic radiotherapy (SABR), uses higher doses of radiation and fires beams at the tumour from multiple directions.
This allows
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
